Risicoanalyse is nog niet beschikbaar voor aanbestedingen uit dit land. Momenteel ondersteund: Estland, Letland, Litouwen, Polen, Frankrijk, VK, Denemarken, Nederland, Noorwegen en Finland.
Ontvang een AI-gestuurde winnende strategie, afgestemd op deze aanbesteding. Inclusief winstkansscore, belangrijke kansen en uitdagingen, aanbevolen focusgebieden voor de inschrijving, inzichten in concurrentiepositie en actiegerichte aanbevelingen om je kansen te maximaliseren.
InloggenUpgrade om te zien welke bedrijven waarschijnlijk op deze aanbesteding zullen inschrijven, gebaseerd op historische inkoopgegevens.
Inloggen9 vereisten over 5 categorieën
Meld je aan om volledige vereisten en analyse te bekijken
3 documenten beschikbaar met AI-samenvattingen
This document is an OCDS release package detailing a preliminary market engagement by NHS Supply Chain for a potential £3 billion framework agreement over eight years for insulin pumps, continuous glucose monitoring devices, and related diabetes technologies.
This notice invites suppliers to participate in preliminary market engagement for a potential £3 billion, eight-year framework agreement for insulin pumps, continuous glucose monitoring devices, and associated diabetes technologies for NHS Supply Chain.
Meld je aan om document samenvattingen en analyse te bekijken
This is a well-structured preliminary market engagement notice for a significant framework agreement. While it lacks formal tender elements like evaluation criteria and e-submission, this is appropriate for its 'planning' status and PME nature.
The notice clearly defines itself as a preliminary market engagement (PME) and references the UK Procurement Act 2023, indicating compliance with national regulations for this stage. The CPV code is appropriate, and there are no disputes or suspensions.
The description is very clear and unambiguous, explaining the purpose, scope, and potential duration/value of the future framework agreement. The requirements, as extracted, are clear within the context of a PME.
Basic information (title, reference, organization, value, duration) is present. Requirements for PME participation are defined. However, one document failed to download, which is a minor completeness issue.
The PME is explicitly open and voluntary, indicating a fair approach to market engagement. Requirements are generic and not tailored. The absence of e-submission is a minor drawback for equal access.
The lack of e-submission functionality is a significant practical drawback for participation. Other practical details like contract start date and duration are clearly specified.
Data is largely consistent and logical, with dates aligning appropriately. The estimated values in GBP and EUR are roughly consistent. The 'Liable Person' field is empty, which is a minor inconsistency.
The notice explicitly mentions 'encouraging openness to innovation' and 'advanced diabetes technologies,' which is a positive. However, there are no explicit green procurement or social criteria mentioned.
Meld je aan om volledige vereisten en analyse te bekijken
Geen creditcard vereist • Setup in 2 minuten
Onze inkoopexperts bereiden alles voor. Bewezen effectief — jij beoordeelt, keurt goed en dient in.
Hallo! Ik ben je AI-assistent voor deze aanbesteding. Ik kan je helpen bij het begrijpen van vereisten, deadlines, geschiktheidscriteria en strategische inzichten bieden.
Geen creditcard vereist